Home » Topics » Conferences

Conferences
RSS

Novartis describes search for potent and selective CDK1/CDK2 inhibitors

Sep. 2, 1998

Potent new antimalarial trioxanes developed at Johns Hopkins

Sep. 2, 1998

SNAP-8719: a valuable tool for studying alpha1D-adrenoceptor function

Sep. 2, 1998

PEG-hirudin more effective than heparin in patients with acute coronary syndromes

Sep. 2, 1998

News from the ACS: Btk inhibitor LFM-A13 promotes apoptosis in leukemia cells

Sep. 1, 1998

Novartis continues to study DPP IV inhibitors; new lead reported at ACS meeting

Sep. 1, 1998

Profile of TI-138067, a novel tubulin inhibitor in phase I testing

Sep. 1, 1998

Novo Nordisk describes the first nonpeptide competitive glucagon antagonist

Sep. 1, 1998

PD-165167 shows excellent selectivity for dopamine D4 receptors

Sep. 1, 1998

ProScript team describes novel Ras endoprotease inhibitor at ACS meeting

Sep. 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...